Mirum Pharmaceuticals Patent-Cliff Exposure & CMS Drug Spending Portfolio
Mirum Pharmaceuticals (Foster City, CA): 3 reconciled FDA prescription therapies, $131.2M 2024 CMS Part D & Medicaid spend, and 7 CA HCAI SB 17 wholesale price filings.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Headquarters / Cluster | Foster City, CA |
| Reconciled FDA Portfolio Therapies | 3 |
| 2025 to 2030 Patent-Cliff Revenue Exposure | 0.0% |
| Primary Portfolio LOE Date | 2032-01-01 |
| 2024 CMS Total Public Spend | $131.2M |
| 2024 Medicare Part D Spend | $13.8M |
| 2024 Medicaid Spend | $117.4M |
| California HCAI SB 17 Filings | 7 WAC filings (max 21.7% 2-yr change) |